Filing Flows › Progyny (PGNY) › Q2 2026
Progyny (PGNY) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 7, 2026
Progyny (PGNY) reported revenue of $351M for the second quarter 2026 (Q2 2026), +5% from a year earlier and +7% from the quarter before. Operating margin was 11.4%, net earnings $28.1M (8.0% of revenue).
Progyny, Q2 2026: revenue $351M (+5% year over year), operating margin 11.4%, net earnings $28.1M, operating cash flow $50.4M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $351M | +7% | +5% |
| Gross profit | $89.3M | +7% | +13% |
| Operating profit | $40.0M | +13% | +64% |
| Net earnings | $28.1M | +16% | +64% |
| Operating cash flow | $50.4M | +10% | -9% |
| Free cash flow | $44.2M | +12% | -12% |
What changed
Revenue was $350.5M in Q2 2026, up 5% year over year and up 7% from the previous quarter. Fertility benefits services revenue was the largest line at 66% of revenue. Fertility benefits services revenue added $16.3M year over year (up 8%), 92% of the total change.
Gross margin was 25.5%, up 1.8 points from Q2 2025. Operating profit was $40.0M, a 11.4% margin (up 4.1 points year over year). Of the extra revenue versus Q2 2025, 89% reached operating profit, above the 7% margin then. Operating expenses fell 10% while revenue rose 5%. Net earnings were $28.1M, up 64% year over year. The effective tax rate was 31.8%.
Operating cash flow was $50.4M (down 9% year over year), 180% of net earnings. Non-cash charges added back $1.6M of depreciation and amortization and $20.5M of share-based compensation. Capital expenditures of $6.2M left free cash flow of $44.2M.
Questions
What was Progyny's revenue in the second quarter 2026?
Progyny (PGNY) reported revenue of $351M for the second quarter 2026 (Q2 2026), +5% from a year earlier and +7% from the quarter before.
Was Progyny profitable in the second quarter 2026?
Operating profit was $40.0M (11.4% of revenue) and net earnings $28.1M.
Source: Progyny 10-Q on SEC EDGAR.